Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Restocking of Isoflurane to commence from February
Zoetis supplies around two-thirds of the UK’s isoflurane anaesthetic gas.

Zoetis issues update on IsoFlo supply

Restocking of the supply chain of IsoFlo - the leading brand of Isoflurane in the UK - is scheduled to commence from February, manufacturer Zoetis has confirmed.

In a press release, the animal health firm said: ‘Close communication and partnership will be maintained with wholesalers, the VMD, BVA, BSAVA, BEVA, and industry stakeholders alongside our veterinary customers to ensure the smoothest transition back to restocking and meeting the industries demand for IsoFlo.

‘Starting from February we will be managing a series of deliveries of IsoFlo back into the UK supply chain until will are able to meet the full demand. This may take several months to complete.’

Zoetis supplies around two-thirds of the UK’s isoflurane anaesthetic gas. But in December, it was announced that their third-party manufacturer had to cease production due to a mechanical issue on the production line.

The supply problem raised concerns by some vets they would not be able to perform emergency surgery over the Christmas period, and that they may be disciplined by the RCVS for clinical decisions that may arise from the shortage.

In response, the RCVS published a statement to reassure the profession that any problems that might arise from the shortage are unlikely to be considered a professional conduct issue. The shortage also prompted the BSAVA to commission a webinar discussing alternative solutions.

 

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.